SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
December 9, 2020
Date of Report (Date of earliest event reported)
PETVIVO HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
|(State or other jurisdiction|
5251 Edina Industrial Blvd.
|(Address of principal executive offices)||(Zip Code)|
Registrant’s telephone number, including area code
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|[ ]||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|[ ]||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|[ ]||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|[ ]||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Securities registered pursuant to Section 12(b) of the Act:
|Title of each class||Trading Symbol(s)||Name of each exchange on which registered|
Item 8.01 Other Events
On December 7, 2020, PetVivo Holdings Inc. (the “Company”) completed the exercise of warrants for the issuance of 637,059 shares of restricted common stock of the Company, wherein the Company received proceeds of $353,922 as a result of the exercise.
The warrants were issued in connection with the Company’s private placement offering of units completed in December 2017 and wherein the warrants were set to expire on December 7, 2020. The exercise price of the warrants was $0.55 per share. As of the expiration date approximately 97% of the warrants had been exercised.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|PETVIVO HOLDINGS, INC.|
|Date: December 9, 2020||By:||/s/ John Lai|
|Title:||Chief Executive Officer|